Fred Alger Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
BG
Fred Alger Management's AMED Position: Q3 2022 in Review
Fred Alger Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 13,560 shares — an estimated $1.43M sold.
Fred Alger Management first reported a position in AMED in Q3 2015 and held it in 4 quarters. The position peaked at $4.36M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.
- Fred Alger Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
- Fred Alger Management sold 13,560 Amedisys shares in Q3 2022, an estimated $1.43M.
- Fred Alger Management first reported a position in Amedisys in Q3 2015 and held it in 4 quarters.
- Fred Alger Management's Amedisys position peaked at $4.36M in Q1 2022.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.
Based on Fred Alger Management's 13F filing for Q3 2022, filed 15 Nov 2022.